Microscopy Studies of Synapses in Alzheimer's Disease Tissue
Seminars in Cell & Development Biology. 2023 Apr; 139: 13-23.
Authors: Griffiths J, Grant SGN.
INTRODUCTION
- Synapse loss and damage are central features of Alzheimer's disease (AD) and contribute to the onset and progression of its behavioral and physiological features. The term "synapse pathology" encompasses a multitude of pathological changes at the synapse. These include synaptic loss, dysfunction, and toxic accumulation or aggregation of proteins within the synapse.
- The study summarizes observations of synapse pathology in AD made using electron microscopy (EM), diffraction-limited light microscopy, and super-resolution nanos copy (SRN), including abnormalities in synapse density, altered morphology of dendritic spines, changes in synaptic protein levels and synaptic targets, and altered synaptic mitochondrial number.
Electron Microscopy Studies
- EM approaches have been at the forefront of studies showing a correlation between synapse loss and cognitive decline. In cases with mild cognitive impairment (MCI) – a presumed prodromal AD transitional state, synapse loss was first observed in the CA1 regions of the hippocampus, inferior temporal cortex, and posterior cingulate cortex. In late-stage AD, synapse loss was further observed in the outer molecular layer of the dentate gyrus and the precuneus cortex.
- Focused ion beam milling and scanning EM (FIB/SEM) has also been used to reveal region- and layer-specific changes in dendritic spine morphology in the trans entorhinal cortex, entorhinal cortex, and the CA1 region of the hippocampal formation. In the entorhinal cortex, layer II spines were described as being larger and more complex, whereas layer III spines were smaller and "simple" when compared with controls.
Diffraction-Limited Light Microscopy Studies
- Although EM has regularly been used to study synapse morphology in post-mortem human AD brains, it lacks the molecular specificity and throughput that can be achieved by light microscopy. Light microscopy has been used with a range of tissue staining methods, including the classical Golgi method and antibody staining. Recently, Golgi-Cox staining and 3D modeling have been used to assess dendritic spine structure in AD.
- To go beyond the axial resolution of light microscopy (~70 nm), ultra-thin tissue sectioning and deconvolution methods have been used in array tomography and fluorescence deconvolution tomography. Combined with fluorescent antibody labeling of inhibitory and excitatory synaptic proteins, these methods have been used to study synapse numbers and their association with plaque location, oligomeric Aβ, genotype, and the ratio of excitatory and inhibitory synapses in AD post-mortem brain tissue.
Super-Resolution Nanoscopy Studies
- In contrast to conventional fluorescence light microscopy, which is constrained by light diffraction limitations, SRN can resolve the subsynaptic localization of labeled proteins, revealing their differential distribution within and between synapses.
- In APP/PS1 mice, stimulated emission depletion (STED) nanoscopy revealed changes in hippocampal spine head and neck morphology. The morphology of a whole human amyloid plaque was reconstructed using STED and array tomography. STED has also been used to resolve tau filament structures in AD cortical grey matter and to validate potentially novel synaptic biomarkers from CSF in preclinical AD.
RELATED PRODUCTS & SERVICES
Reference
- Griffiths J and Grant SGN. (2023). "Synapse pathology in Alzheimer's disease." Semin Cell Dev Biol. 139, 13-23.
For research use only. Not for any other purpose.
Resources
- FAQ
- Posters & Downloads
- Protocol
- Tools
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Comparison of the MSCs from Different Sources
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Techniques for Cell Separation
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- STR Profiling—The ID Card of Cell Line
- How to Assess the Migratory and Invasive Capacity of Cells?
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Quantification of Cytokines
- T Cell Activation and Expansion
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Cell Culture Medium
- IL-12 Family Cytokines and Their Immune Functions
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What are the Differences Between M1 and M2 Macrophages?
- Human Primary Cells: Definition, Assay, Applications
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- How to Eliminate Mycoplasma From Cell Cultures?
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- From Shake Flask to Bioreactor: 7 Scale-Up Risks
- How to Interpret ddPCR Results: Common Pitfalls and Troubleshooting
- ddPCR Assay Design for Gene Rearrangement Detection
- Why Your Cells Won't Detach? And How to Fix It?
- How to Identify and Troubleshoot Cell Morphology Changes
- Cell Clumping in Suspension Culture: Causes & Solutions
- Cell Culture Troubleshooting: Molecular Diagnostics & QC for Preclinical R&D
- Cell Density vs. Confluency: How to Optimize Cell Growth
- Cell Immortalization Step by Step
- Cell-Based High-Throughput Screening Techniques
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Adherent and Suspension Cell Culture
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Role of Cell-Based Assays in Drug Discovery and Development
- Immunogenicity Testing: ELISA and MSD Assays
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Overview of Cell Apoptosis Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- ddPCR vs qPCR vs NGS: Which Platform Fits Your Research?
- Cell Viability, Proliferation and Cytotoxicity Assays
- What Are CAR T Cells?
- Eosinophils vs. Basophils vs. Neutrophils
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Understanding Immunogenicity Assays: A Comprehensive Guide
-
Histology
- Fluorescent Nuclear Staining Dyes
- Troubleshooting in Fluorescent Staining
- Stains Used in Histology
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- Cell Lysates: Composition, Properties, and Preparation
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Tips for Choosing the Right Protease Inhibitor
- Multiple Animal Tissue Arrays
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Guides for Live Cell Imaging Dyes
- Mitochondrial Staining
- How to Choose the Right Positive and Negative Controls for IHC
- How to Optimize IHC Antibody Dilution: A Practical Guide
- Why Is My IHC Background Too High? A Step-by-Step Troubleshooting Guide
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- What You Must Know About Neuroscience IHC?
- Modern Histological Techniques
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Multiplexing Immunohistochemistry
- From Specimen to Slide: Core Methods in Histological Practice
- Serum vs. Plasma
- How to Begin with Multiplex Immunohistochemistry (mIHC)
-
Exosome
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- Exosome Transfection for Altering Biomolecular Delivery
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- How to Apply Exosomes in Clinical?
- Techniques for Exosome Quantification
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Perform Targeted Modification of Exosomes?
- How to characterize exosomes?
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- The Role of Exosomes in Cancer
- How to Enhancement Exosome Production?
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- What's the Potential of PELN in Disease Treatment?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- How to Label Exosomes?
- Unraveling Biogenesis and Composition of Exosomes
-
ISH/FISH
- ISH probe labeling method
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- Multiple Approaches to Karyotyping
- Overview of Common FISH Techniques
- In Situ Hybridization Probes
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Guidelines for the Design of FISH Probes
- Small RNA Detection by ISH Methods
- Differences Between DNA and RNA Probes
- Overview of Oligo-FISH Technology
- How to Use FISH in Hematologic Neoplasms?
- FISH Tips and Troubleshooting
- CARD-FISH: Illuminating Microbial Diversity
- What are the Differences between FISH, aCGH, and NGS?
- Comparative Genomic Hybridization and Its Applications
- Telomere Length Measurement Methods
- Different Types of FISH Probes for Oncology Research
- RNAscope ISH Technology
- What Is the Use of FISH in Solid Tumors?
- What Types of Multicolor FISH Probe Sets Are Available?
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- How to Improve ISH Signal-to-Noise Ratio
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- Traditional vs. Novel Drug Delivery Methods
- Key Factors Influencing Brain Distribution of Drugs
- Overview of In Vitro Permeability Assays
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Key Considerations in Toxicokinetic
- Organ-on-a-Chip Systems for Drug Screening
- How to Design and Synthesize Antibody Drug Conjugates?
- What factors influence drug distribution?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- How to Conduct a Bioavailability Assessment?
- Experimental Methods for Identifying Drug-Drug Interactions
- Physical and Chemical Properties of Drugs and Calculations
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Unraveling the Role of hERG Channels in Drug Safety
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- Pharmacokinetics of Therapeutic Peptides
- How to Use iPSC-Derived Hepatocytes in Toxicity Studies
- In Vitro ADME vs In Vivo PK: Why Do Results Diverge?
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- The Bioanalysis Masterclass: Labile Metabolites
- What Are Biomarkers in Drug Discovery?
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- Bioanalysis Errors: How to Spot and Fix Them Early
- Troubleshooting Common Issues in Drug Toxicity Testing
- A Complete Guide to CYP Reaction Phenotyping in 2026
- In Vitro ADME vs In Vivo ADME
- Mastering the Noise: A Practical Guide to Minimizing Variability in Preclinical Studies
- Reaction Phenotyping vs. Metabolic Stability
- How to Interpret CYP Phenotyping Data
- When Should You Introduce ADME Tox Testing in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- How Are Biomarkers Validated in Drug Development?
- The Essentials of Quantitative Bioanalysis
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- Why iPSC-derived Cells are Useful in Toxicology?
- Comparing Plasma Protein Binding Methods
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How Can You Optimize Drug Toxicity Assessment?
- Why Cardiotoxicity Matters in R&D?
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- The 8 Types of Drug Toxicity Every Researcher Must Know
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Animal Models of Neurodegenerative Diseases
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Scaling Organoid Screening: A Hands-On Guide for 3D Drug Discovery
- Bridging the Translational Gap: A Systematic Framework for Model Selection
- Advanced Organoid Culture: A Practical Optimization Guide
- Are You Choosing the Right Preclinical Model? 10 Key Questions
- How to Match Models to Drug Modalities: Small Molecules vs. Biologics
- How to Select the Right Preclinical Model for Drug Development
- Humanized Mouse Models: Core Technical Considerations
- Animal Models vs. NAMs: Understanding Modern Preclinical Research
- How to Select the Right Humanized Mouse Model for Immuno-Oncology
- Organoids vs Organ-on-Chip: Which is More Predictive?
- Implementing NAMs in Drug Development
- Organ-on-a-Chip: Is Your Microfluidic Setup Ready for Preclinical Trials?
- Why Oncology Organoids Fail? How to Build Models That Work
- Oncology Model Strategy: From Screening to Validation
- Static vs. Dynamic In Vitro Models
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter





